News on research grants, RFPs, government funding trends in genetics, genomics, and molecular diagnostics.
The NIH is aiming to fund projects evaluating the clinical potential of cancer biomarker assays that are already validated for research use.
The company is developing a companion diagnostic to identify head and neck cancer patients most likely to benefit from Erbitux.
The assays should be easy to perform and capable of detecting HIV from a finger-stick blood or other sample shortly after infection or treatment interruption.
The initiative includes academic and private sector partners and aims to train new researchers in the early diagnosis of brain cancer.
The grant is specifically intended to support the development of noninvasive, rapid tests that can be used at the point of care in developing country settings.
